← FDA Drug Approvals (Drugs@FDA)
DAYVIGO
NDA · New Drug Application · Sponsor: EISAI INC · Approved 2019-12-20
Drug application
- FDA Application #
NDA212028- Application type
- New Drug Application
- Brand name
- DAYVIGO
- Generic name
- LEMBOREXANT
- Active ingredients
- LEMBOREXANT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- EISAI INC
- Manufacturer
- Eisai Inc.
- First approval
- 2019-12-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown